This overview page provides a quick summary of the selected assets, including their latest prices, price changes, market capitalization changes, and more.
This page just gave you an overview, you might also want to check out the comprehensive stats, historical, correlation, volatility, and price projection pages.
Arcus Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer immunotherapies. The company operates within the biotechnology industry, specifically targeting the discovery and development of treatments for various cancers. Its pipeline centers on immuno-oncology, aiming to harness the body's own immune system to fight malignant tumors. Key products in development include candidates targeting the adenosine pathway and the TIGIT pathway, both of which are critical in modulating the immune response to cancer. Arcus is pursuing combination therapies, believing that targeting multiple immune checkpoints simultaneously can lead to more durable and effective anti-cancer responses. The company has established strategic collaborations with larger pharmaceutical companies, which provides significant resources and expands the potential reach of its drug candidates. Arcus's market position is characterized by its innovative approach to immuno-oncology and its commitment to addressing unmet needs in cancer treatment.
Read moreThis website uses cookies for essential functions, other functions, and for statistical purposes. Please refer to the cookie policy for details.
This feature requires functional cookies. Please refer to the cookie policy for details.
We sent you a verification email. Copy and paste the verification code above.
Trade hundreds of crypto perpetual futures